Privacy Statement

Oakwood is aware that the security of your private information from the use of our website is an important concern. We take the protection of your personal data very seriously. We would like you to know what data we maintain and what data we discard. This privacy statement should inform you about our security measures.

Collection of Data
You can use our online-presentation, in principle, without disclosing your personal data. By using our website, data is stored on our servers for safeguarding purposes, e.g. the name of your internet service provider, the website that you used to link to our site, the websites that you visit from our site and your IP-Address.

Collection and Processing of Personal Data
Personal data is only collected if you provide it to us, i.e. as part of the registration, through completion of forms or e-mails, as part of an order for products or services, or inquiries or requests about materials being ordered.

The database and its contents remain at our company and stay with our provider. Your personal data is not passed on by us or by our agents for use by third parties in any form whatsoever, unless we have obtained your consent or are legally required to do so.


Oakwood Labs

Oakwood Laboratories was founded as the research division of Ben Venue Laboratories, the largest and most experienced parenteral company in the world. In 1997 it was spun off as a separate entity when Ben Venue was acquired by Boehringer-Ingelheim. Oakwood's founders, Edward C. Smith and Mark T. Smith were C.E.O and the Director of Business Development of Ben Venue and were responsible for starting Ben Venue's generic division, Bedford Laboratories.